Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 5.1% in November

Cibus, Inc. (NASDAQ:CBUS) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 2,050,000 shares, a growth of 5.1% from the November 15th total of 1,950,000 shares. Currently, 11.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 204,400 shares, the days-to-cover ratio is currently 10.0 days.

Cibus Stock Performance

CBUS stock traded down $0.06 during trading on Tuesday, hitting $3.83. The stock had a trading volume of 44,509 shares, compared to its average volume of 134,416. Cibus has a 1-year low of $2.86 and a 1-year high of $23.18. The stock has a market cap of $101.33 million, a price-to-earnings ratio of -0.17 and a beta of 1.86. The company’s 50 day moving average price is $4.16 and its two-hundred day moving average price is $6.47.

Analyst Upgrades and Downgrades

CBUS has been the subject of several recent research reports. HC Wainwright restated a “buy” rating and set a $25.00 target price on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group reissued a “buy” rating and set a $20.00 price objective on shares of Cibus in a research note on Tuesday, October 22nd. Finally, Alliance Global Partners reduced their target price on Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th.

Hedge Funds Weigh In On Cibus

A number of institutional investors have recently modified their holdings of the company. Old West Investment Management LLC grew its stake in Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock worth $524,000 after acquiring an additional 1,868 shares during the period. HighTower Advisors LLC grew its position in shares of Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after purchasing an additional 2,750 shares during the period. FineMark National Bank & Trust increased its stake in Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after purchasing an additional 4,000 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in Cibus by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after purchasing an additional 6,276 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Cibus in the 3rd quarter worth about $33,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.